Sunday, April 12, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Chevron Expands Global Energy Footprint with New Projects

Kennethcix by Kennethcix
February 16, 2026
in Analysis, Energy & Oil, Mergers & Acquisitions
0
Chevron Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The international energy giant Chevron is accelerating its growth strategy across multiple continents. Recent developments in Greece, Venezuela, and Libya are significantly expanding the company’s access to new hydrocarbon resources, though the timeline for converting these opportunities into operational projects remains a key consideration for investors.

Strategic Entry into the Eastern Mediterranean

A Chevron-led consortium has signed exclusive lease agreements to explore for natural gas in four deepwater blocks off the coast of southern Greece, according to reports. The exploration areas, covering approximately 47,000 square kilometers, are situated south of the Peloponnese peninsula and the island of Crete.

This agreement follows an international tender won by Chevron and Hellenic Energy back in October 2025. Before seismic studies can commence later this year, the leases require final approval from the Greek parliament. This move aligns with broader European energy security efforts, reigniting Greece’s search for domestic gas reserves as the EU reduces reliance on Russian supplies while still classifying natural gas as a transitional fuel.

Regulatory Shifts Ease Path in Venezuela

Separately, Chevron’s operations in Venezuela have received a substantial boost from U.S. regulators. The Office of Foreign Assets Control (OFAC) issued two new general licenses last Friday, marking what analysts describe as the most significant easing of Venezuela sanctions since the removal of President Nicolás Maduro by U.S. forces last month.

General License 50 authorizes Chevron, along with BP, Eni, Shell, and Repsol, to conduct oil and gas operations within the country. These firms, already present as partners with the state-owned PDVSA, must process any license fees and taxes through the U.S.-controlled Foreign Government Deposit Fund.

Should investors sell immediately? Or is it worth buying Chevron?

Going a step further, General License 49 permits companies globally to negotiate contracts with PDVSA for new oil and gas investments. However, such deals remain contingent on separate OFAC approvals. The license explicitly prohibits transactions involving entities based in Russia, Iran, or China. A Chevron spokesperson welcomed the licenses as “important steps” to develop Venezuelan resources and support regional energy security.

North African Expansion Gains Momentum

In North Africa, Chevron secured a position in Libya on February 11. The company was named the winning bidder for Contract Area 106 in the Sirte Basin as part of the Libya 2025 Bidding Round. This award followed a Memorandum of Understanding (MoU) signed with Libya’s National Oil Corporation on January 24.

The final grant of the contract is contingent upon the signing of a Production Sharing Agreement. Chevron also reported an additional MoU in Syria during February, signaling a broader strategy to strengthen its regional presence.

For shareholders, the immediate focus shifts to a key date this week: the ex-dividend date for the company’s quarterly dividend of $1.78 is tomorrow. In the previous trading session, Chevron shares closed at $183.74.

Ad

Chevron Stock: Buy or Sell?! New Chevron Analysis from April 12 delivers the answer:

The latest Chevron figures speak for themselves: Urgent action needed for Chevron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 12.

Chevron: Buy or sell? Read more here...

Tags: Chevron
Kennethcix

Kennethcix

Related Posts

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

April 11, 2026
Strategy Stock
Analysis

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
Orora Stock
European Markets

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

April 10, 2026
Next Post
Tyler Stock

Tyler Technologies Unveils $1 Billion Share Repurchase Initiative

Palantir Stock

A Legendary Short Seller Takes Aim at Palantir's Core

Ge Vernova Stock

Institutional Investors Amplify Stakes in GE Vernova Amid Lofty Valuation

Recommended

Infineon Stock

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

4 weeks ago
Asbury Automotive Stock

Asbury Automotive’s Expansion Strategy Faces Market Skepticism

8 months ago
ePlus Stock

ePlus Stock: A Quiet Transformation Gains Momentum

7 months ago
Rimini Stock

Rimini Street Stock: Executive Sales Cloud Strong Growth Narrative

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

iShares MSCI World ETF: Stability Anchored by a Handful of Tech Titans

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

Ams Osram’s Gold Problem Meets AI Optimism

Trending

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

by Jackson Burston
April 11, 2026
0

ImmunityBio's stock is navigating a volatile path, caught between explosive commercial growth for its bladder cancer drug...

Strategy Stock

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
BioNTech Stock

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

April 11, 2026
Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

April 11, 2026
Orora Stock

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

April 10, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio’s Record Revenue Meets Mounting Legal Pressure
  • Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction
  • BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com